19
Views
32
CrossRef citations to date
0
Altmetric
Original Article

Epitopes on Human Acetylcholine Receptor Defined by Monoclonal Antibodies and Myasthenia Gravis Sera

, , &
Pages 285-297 | Published online: 07 Jul 2009

References

  • Lindstrom J. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton Syndrome. Ann Rev Immunol 1985; 3: 109–131
  • Willcox H NA, Vincent A. Myasthenia gravis as an example of organ-specific autoimmune disease. ‘The B lymphocyte in Human Disease’, A. G. Bird, J. E. Calvert. Oxford University Press. 1988; 469–506
  • Lindstrom J M, Seybold M E, Lennon V A, Whittingham S, Duane D D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology (NY) 1976; 26: 1054–1059
  • Vincent A, Newsom-Davis J. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalised myasthenia or disease restricted to ocular muscles. Clin Exp Immunol 1982; 49: 251–265
  • Rodgaard A, Nielsen F C, Djurup R, Somnier F, Gammeltoft S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clin Exp Immunol, 67: 82–88
  • Bray J J, Drachman D B. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis. J Immunol 1982; 33: 1316–1321
  • Lindstrom J, Campbell M, Nave B. Specificities of antibodies to acetylcholine receptors. Muscle & Nerve 1978; 1: 140–145
  • Tzartos S J, Seybold M E, Lindstrom J M. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Nat Acad Sci 1982; 79: 188–192
  • Whiting P, Vincent A, Newsom-Davis J. Myasthenia gravis: monoclonal anti-human acetylcholine receptor antibodies used to analyse antibody specificities and responses to treatment. Neurology 1986; 366: 12–617
  • Tzdrtos S J, Lindstrom J M. Monoclonal antibodies used to probe acetylcholine receptor structure: localisation of the main immunogenic region and detection of similarities between subunits. Proc Nat Acad Sci 1980; 77: 755–759
  • Whiting P J, Vincent A, Schluep M, Newsom-Davis J. Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor. J Neuroimmunol 1986; 11: 223–235
  • Vincent A, Whiting P, Schluep M, Heidenreich F, Lang B, Roberts A, Newsom-Davies J. Antibody heterogeneity in myasthenia gravis. Ann N. Y. Acad Sci DB Drachman 1987; 505: 106–120, ‘Myasthenia Gravis’
  • Vincent A, Wood H. Antigenic specificity of monoclonal antibodies against Torpedo and human acetylcholine receptor, and use of these antibodies to investigate myasthenia gravis. ‘Nicotinic acetylcholine receptor’, A. Maelicke. Springer-Verlag, Berlin 1986; 93–102, NATO AS1 series Vol H3
  • Schluep M, Willcox N, Vincent A, Dhoot G K, Newsom-Davies J. Acetylcholine receptors in human myoid cells in situ: an immunohistological study. Ann Neurol 1987; 22: 212–222
  • Mischina M, Takai T, Imoto K, Noda M, Takahashi T, Numa S, Methfessel C, Sakmann B. Molecular distinction between fetal and adult acetylcholine receptor. Nature 1986; 321: 406–411
  • Schuetze S M, Vicini S, Hall Z W. Myasthenic serum selectively blocks acetylcholine receptors with long channel open times at developing rat endplates. Proc Natl Acad Sci 1985; 82: 2533–2537
  • Kubalek E, Ralston S, Lindstrom J, Unwin N. Location of subunits within the acetylcholine receptor by electron image analysis of tubular crystals from Torpedo mamorata. J Cell Biol 1987; 105: 9–18
  • Whiting P J, Vincent A, Newsom-Davis J. Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding site. Eur J Biochem 1985; 150: 533–539
  • Vincent A. Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis?. J Autoimmunity 1988, in press
  • Sikorska H M. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditiis and Grave's disease. J Immunol 1986; 137: 3786–3795

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.